Echo Street Capital Management’s Charles River Laboratories CRL Stock Holding History

Echo Street Capital Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,603	Closed	-$314K	–	101
2023 Q3	$314K	Buy	+1,603	New	+$329K	﹤0.01%	360
2023 Q2	–	Sell	-2,599	Closed	-$525K	–	481
2023 Q1	$525K	Sell	2,599 -362	-12%	-$82K	﹤0.01%	251
2022 Q4	$645K	Buy	+2,961	New	+$647K	0.01%	232
2022 Q3	–	Sell	-2,278	Closed	-$487K	–	577
2022 Q2	$487K	Buy	2,278 +84	+4%	+$20.5K	﹤0.01%	325
2022 Q1	$623K	Sell	2,194 -211,143	-99%	-$65.1M	﹤0.01%	355
2021 Q4	$80.4M	Buy	213,337 +32,115	+18%	+$12.5M	0.54%	80
2021 Q3	$74.8M	Buy	+181,222	New	+$75.3M	0.53%	83
2021 Q2	–	Sell	-895	Closed	-$259K	–	618
2021 Q1	$259K	Sell	895 -260	-23%	-$72.3K	﹤0.01%	448
2020 Q4	$289K	Buy	+1,155	New	+$275K	﹤0.01%	325
2020 Q3	–	Sell	-3,697	Closed	-$645K	–	172
2020 Q2	$645K	Buy	+3,697	New	+$590K	0.01%	323

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Echo Street Capital Management's CRL Position: Q4 2023 in Review

Echo Street Capital Management sold out of Charles River Laboratories (CRL) in Q4 2023, closing a stake of 1,603 shares — an estimated $314K sold.

Echo Street Capital Management first reported a position in CRL in Q2 2020 and held it in 10 quarters. The position peaked at $80.4M in Q4 2021. 634 funds tracked by Wall St. Rank hold CRL as of Q4 2023.

Echo Street Capital Management reported no remaining Charles River Laboratories position as of Q4 2023 after selling out during the quarter.
Echo Street Capital Management sold 1,603 Charles River Laboratories shares in Q4 2023, an estimated $314K.
Echo Street Capital Management first reported a position in Charles River Laboratories in Q2 2020 and held it in 10 quarters.
Echo Street Capital Management's Charles River Laboratories position peaked at $80.4M in Q4 2021.
634 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2023.

Based on Echo Street Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.